ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Anthem Biosciences reported Q1FY27 revenue of ₹418.2 Crore and profit after tax of ₹119.9 Crore. The company continues its focus on margin improvement and cost efficiencies.
Anthem Biosciences reported FY26 consolidated revenue of ₹2124.3 Crore with a 26% PAT margin. Strong quarterly performance was driven by 30.7% YoY growth in CRDMO segment.